Wnt signaling regulates ␤-catenin-mediated gene transcription and planar cell polarity (PCP). The Wnt co-receptor, Lrp6, is required for signaling along the ␤-catenin arm. We show that Lrp6 downregulation (by morpholino injection) or overexpression in Xenopus embryos disrupts convergent extension, a hallmark feature of Wnt/PCP components. In embryos with decreased Lrp6 levels, cells of the dorsal marginal zone (DMZ), which undergoes extensive cellular rearrangements during gastrulation, exhibit decreased length:width ratios, decreased migration, and increased numbers of transient cytoplasmic protrusions. We show that Lrp6 opposes Wnt11 activity and localizes to the posterior edge of migrating DMZ cells and that Lrp6 downregulation enhances cortical and nuclear localization of Dsh and phospho-JNK, respectively. Taken together, these data suggest that Lrp6 inhibits Wnt/PCP signaling. Finally, we identify the region of the Lrp6 protein with Wnt/PCP activity to a stretch of 36 amino acids, distinct from regions required for Wnt/␤-catenin signaling. We propose a model in which Lrp6 plays a critical role in the switch from Wnt/PCP to Wnt/␤-catenin signaling.
INTRODUCTION
Studies have shown the existence of at least two Wnt pathways that play critical roles in early embryonic development: Wnt/␤-catenin ('canonical') and Wnt/PCP (planar cell polarity or 'noncanonical') signaling. Of the two, the best characterized is the Wnt/␤-catenin pathway (reviewed by Clevers, 2006) . In the absence of a Wnt signal, cytoplasmic ␤-catenin is normally maintained at low levels due to its degradation by a complex consisting of Axin, the tumor suppressor APC (adenomatous polyposis coli), and the kinases CKI␣ and GSK3. Activation of Wnt/␤-catenin signaling occurs upon binding of Wnt ligands to members of the Frizzled (Fz) and low-density lipoprotein receptor-related protein family of receptors (Tamai et al., 2000; Wehrli et al., 2000) . Wnt binding initiates a series of events resulting in ␤-catenin stabilization and consequent activation of gene transcription by binding of ␤-catenin to members of the TCF/LEF family of transcription factors.
Wnt/PCP signaling controls convergent-extension movements of the axial and paraxial mesoderm and neural ectoderm during embryonic development in Xenopus, zebrafish and mice (Jones and Chen, 2007) . In Xenopus embryos, the Wnt/PCP pathway affects cell morphology and motility largely through its modulation of the actin cytoskeleton. Cells acquire distinct polar morphologies that promote directed migration and intercalation during the morphogenetic movements of gastrulation and neurulation. Although numerous genes that regulate Wnt/PCP signaling have been identified, mechanisms by which the signal is transduced are not well understood. Assembly of the actin cytoskeleton as a consequence of Wnt/PCP signaling is thought to occur via cortical recruitment of Dishevelled (Dsh; also known as Dvl -Xenbase) and activation of Jun-N-terminal kinase (JNK) and the Rho family of GTPases (Habas et al., 2001; Yamanaka et al., 2002) .
Lrp6 has been shown to play a critical role in activating Wnt/␤-catenin signaling. Its intracellular domain contains five PPP(S/T)P motifs, each of which is phosphorylated upon Wnt stimulation (Davidson et al., 2005; Zeng et al., 2005) . Each of the five PPP(S/T)P motifs of Lrp6, when phosphorylated, can bind to Axin and, through an as yet undefined mechanism, inhibit ␤-catenin degradation (Tamai et al., 2004) . In the current model of Wnt signaling, Lrp6 signals exclusively in a ␤-catenin-dependent manner (Tamai et al., 2000; Wehrli et al., 2000) . Recently, Dkk1, a secreted Wnt/␤-catenin antagonist that binds Lrp6, was shown to regulate convergent-extension movements in zebrafish via activation of Wnt/PCP signaling (Caneparo et al., 2007) .
Our studies indicate that Lrp6, a previously characterized core Wnt/␤-catenin component, is an essential regulator of convergentextension movements in Xenopus embryos via its inhibition of Wnt/PCP signaling. Furthermore, we show that Lrp6 is asymmetrically distributed in mesodermal cells that participate in convergent extension, suggesting a role for Lrp6 in the establishment and maintenance of cell polarity during embryogenesis.
MATERIALS AND METHODS

Embryo injections, dissections and staining
Xenopus embryos were fertilized in vitro, dejellied, and cultured as previously described (Peng, 1991) . Embryos were staged according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1994) . For microinjections, embryos were kept in 3% Ficoll in 0.2ϫ Marc's modified Ringer's (MMR) medium and fixed at stage 26 for analysis. In vitro-transcribed, capped mRNA was synthesized using the mMessage mMachine Kit (Ambion, Austin, TX, USA). Lrp6MO was from Gene Tools LLC (Philomath, OR, USA). Detection of notochord with monoclonal antibody Tor70 (Kushner, 1984) was performed as described previously (Lane and Keller, 1997) .
Keller sandwiches of uniform width and length were prepared from dorsal marginal zone (DMZ) explants at stage 10+ (Keller and Danilchik, 1988) and cultured in 1ϫ DFA medium (Sater et al., 1993) until stage 18. To determine explant length-to-width ratios, the longest axis of each explant was divided by its widest perpendicular aspect (short axis). Animal pole ectodermal explants (animal caps) were dissected at stage 9 and cultured in 75% MMR in the presence of 10 ng/ml activin (R&D Systems, Minneapolis, MN, USA) until stage 20 when elongation was assessed. At least 28 caps were assessed for each set of injections.
Lrp6 is required for convergent extension during Xenopus gastrulation
For Dsh localization studies, caps were co-injected with 150 pg of Xenopus Dsh-GFP and visualized at stage 11 by confocal microscopy (Zeiss Axiovert LSM 510 META; Carl Zeiss, Jena, Germany). Cells with >90% of staining at their cortex were scored as having cortical Dsh-GFP. JNK (also known as Mapk8) activation was assessed in animal caps (stage 11) using phospho-JNK specific antibody (Promega V7931; Promega, Madison, WI, USA). Picture intensity was normalized to control uninjected and ␤-catenininjected caps. Cells with exclusive nuclear phospho-JNK staining were counted as positive.
RNA extraction and RT-PCR analysis
Injected animal caps were excised at stage 9, cultured in the presence or absence of activin (10 ng/ml) until stage 11, and RNA was extracted for RT-PCR. Whole embryos were harvested at stage 26. RT-PCR primers and conditions were as previously described (http://www.hhmi.ucla.edu/derobertis/index.html). For each primer set, the appropriate number of cycles within the linear amplification range was determined by testing serial dilutions of reverse-transcribed cDNA. Ornithine decarboxylase mRNA was used as control for RNA extraction and reverse transcription.
TOPFLASH reporter assay
For TOPFLASH reporter assays, HEK293 cells were transiently cotransfected and luciferase activity assessed according to the manufacturer's instructions (Promega, Madison, WI, USA). Assays were performed in triplicate with samples normalized to ␤-galactosidase.
Open-faced explants, time-lapse imaging, phalloidin staining and Lrp6 localization
Open-faced 'shaved ' Keller DMZ and ventral marginal zone (VMZ) explants (Shih and Keller, 1992b) were dissected at stage 10.5 from embryos co-injected with mRNA encoding myristoylated GFP (mGFP) plus Xenopus strabismus (stbm) mRNA, Lrp6MO, or lrp6-B mRNA. Explants were filmed by time-lapse confocal microscopy (Zeiss Axiovert LSM 510 META; Carl Zeiss, Jena, Germany) by capturing one frame every 15 seconds over 15 minutes. Randomly chosen cells from each movie were traced and their motility was measured as described (Tahinci and Symes, 2003) . Cell orientations, length-to-width ratios, and protrusion distributions were calculated using ImageJ software (http://rsb.info.nih.gov/ij/) for the middle frame of each movie. Cells from DMZ or VMZ explants were dissociated in 1ϫ modified Barth's saline (MBS) without Ca 2+ or Mg 2+ and plated on 200 g/ml fibronectin (R&D Systems, Minneapolis, MN, USA). After adhering for 30 minutes, cells were fixed and stained with Alexa Fluor 594 phalloidin (Invitrogen, Carlsbad, CA, USA). GFP-positive cells were used for determining morphologies. Length-to-width ratios and protrusion distributions were measured using ImageJ. At least 216 protrusions were measured for each set of injected explants.
For Lrp6 immunolocalization in animal caps, embryos were co-injected with vesicular stomatitis virus G (VSVG)-Lrp6 and mGFP. Embryos were dissected at stage 9 (animal caps) or stage 10. (animal caps) or 11 (DMZs; explants did not undergo appreciable elongation from stage 10.5 to 11), and processed for immunostaining as described previously (Lane and Keller, 1997 , plated on fibronectin-coated slides (200 g/ml; R&D Systems, Minneapolis, MN, USA), and allowed to adhere for 30 minutes. Cells were fixed in 4% formaldehyde and stained with anti-VSVG-FITC (Bethyl Laboratories, Montgomery, TX, USA) and Alexa Fluor 594 phalloidin (Invitrogen, Carlsbad, CA, USA) as described previously (Sawin et al., 1992) .
Antibodies were obtained as follows: rabbit anti-VSVG (Bethyl Laboratories, Montgomery, TX, USA); mouse anti-actin (MP Biomedicals, Solon, OH, USA); Cy2-and Cy3-conjugated secondary antibodies (Jackson Immunoresearch, West Grove, PA, USA). Explants were observed by confocal microscopy (Zeiss Axiovert LSM 510 META; Carl Zeiss, Jena, Germany).
Embryo cryosections
Embryos (stage 10.5) were placed in embedding medium (OCT) with their suprablastoporal regions (prospective chordamesoderm) facing the embedding resin, such that these regions would be sectioned first. Embedded embryos were frozen on dry ice and 10 m sections were made using a Leica CM3050 S cryostat microtome (Leica Microsystems, Bensheim, Germany). Anti-VSVG (1:200) was applied to sections overnight at 4°C. Sections were incubated with Cy3 secondary antibody (1:200), mounted in antifade (90% glycerol, 4% n-propyl gallate), and examined using the FluoView 100 confocal microscope (Olympus, Tokyo, Japan). Cells with Lrp6 staining extending over less than half of their periphery were scored as having polarized Lrp6 distribution.
RESULTS
Loss or gain of Lrp6 function inhibits convergent extension in Xenopus embryos and explants
To assess whether Lrp6 can regulate convergent extension, we performed loss and gain-of-function studies in Xenopus embryos. For loss of Lrp6 function, we injected Lrp6 morpholino oligonucleotides (Lrp6MO) to block translation of endogenous lrp6 mRNA. Lrp6 morphants are anteriorized with expanded heads and cement glands (Fig. 1A) , consistent with the established role of Lrp6 in zygotic Wnt/␤-catenin signaling. In addition, Lrp6MO-injected embryos fail to fully elongate, consistent with defects in convergent-extension movement during gastrulation. To show specificity for Lrp6 knockdown, we performed rescue experiments. Co-injection of Lrp6MO and full-length lrp6 mRNA (lrp6FL) rescues both elongation and Wnt/␤-catenin anteriorization defects (Fig. 1B) . By contrast, co-injection of Lrp6MO with ␤-catenin DNA (which is expressed after the onset of zygotic transcription) suppresses anteriorization, but not embryo elongation defects (Fig. 1B) .
For gain of Lrp6 function, we injected mRNA encoding the intracellular domain of Lrp6 fused to an N-terminal myristoylation sequence (Tamai et al., 2004) . This construct constitutively transduces the Wnt/␤-catenin signal and causes anterior duplication when injected ventrally whereas full-length Lrp6 has only weak 4097 RESEARCH ARTICLE Lrp6 regulates convergent extension canonical activity (Fig. 1A) . Unless otherwise indicated, this constitutively active construct was used in all subsequent studies. Embryos injected in their presumptive neural ectoderm (dorsoanimal blastomeres) fail to fully elongate their anteroposterior (AP) axes and develop with dorsal flexure; they have bifurcated, bent notochords, suggestive of defects in neural convergent extension . Embryos injected in their presumptive axial mesoderm (dorsovegetal blastomeres) develop with closed neural tubes, but have shortened AP axes with thicker notochords, suggestive of defective mesodermal convergent extension (Fig. 1A ). Similar phenotypes are observed when embryos are injected with Xdd, a dominant negative mutant of Dishevelled that affects convergent extension (Sokol, 1996) . The ability of Lrp6 to block gastrulation or neurulation cannot be attributed to Wnt/␤-catenin pathway activation because functionally equivalent amounts of ␤-catenin mRNA that cause a similar percentage of anterior duplication (injected ventrally) do not block AP axis elongation when injected into dorsal blastomeres (Fig. 1A) . These results are reminiscent of studies of Wnt/PCP components in that either loss or gain of Lrp6 function causes gastrulation and/or neurulation defects (Ueno and Greene, 2003) , depending on the injection site.
The gastrulation defects observed in embryos with loss or gain of Lrp6 function can be attributed to either defective patterning or morphogenesis of developing tissues. To distinguish between these two possibilities, we performed RT-PCR analysis of tissue-specific marker genes. We detect proper mesendoderm specification in embryos injected with either Lrp6MO or lrp6 mRNA as evidenced by expression of the following markers: Brachyury (panmesodermal); Goosecoid and Chordin (anterior mesodermal); Sizzled (posterior mesodermal); and the endodermal marker Endodermin (Fig. 1C) . Anterior neural tissue is also present in these embryos as evidenced by expression of Otx2 and Xag1. Lrp6 downregulation by morpholino injection causes a concomitant decrease in expression of epidermal keratin, consistent with anteriorization of neural ectoderm at the expense of epidermis in the absence of Wnt/␤-catenin signaling (Glinka et al., 1998) . These results show that either gain or loss of Lrp6 causes defects in morphogenesis rather than mesendodermal tissue patterning.
We next assessed the role of Lrp6 in regulating convergent extension using Xenopus explants, animal caps and Keller sandwiches (Symes and Smith, 1987; Keller and Danilchik, 1988) . Animal caps from Xenopus blastulae differentiate into round epidermal tissue when cultured in vitro. In the presence of mesoderm-inducing activin, however, their cells intercalate, resulting in cap elongation (Symes and Smith, 1987) . Injection of activators or inhibitors of Wnt/PCP signaling blocks this elongation process (Simons et al., 2005; Takeuchi et al., 2003) . Animal caps from embryos injected with lrp6 mRNA or Lrp6MO fail to elongate with activin treatment, resembling caps injected with Wnt11, an activator of Wnt/PCP signaling ( Fig. 2A) . Inhibition of elongation in lrp6 mRNA-and Lrp6MO-injected caps occurs despite proper induction of mesendodermal markers, confirming that loss and gain of Lrp6 function result in inhibition of convergent extension (Fig.  2B) . Furthermore, this inhibition induced by Lrp6 loss of function cannot be rescued by co-injection of ␤-catenin mRNA, confirming that Lrp6 blocks convergent-extension movements in a ␤-cateninindependent manner (see Fig. S1 in the supplementary material).
Keller sandwiches consist of two apposed dorsal marginal zone (DMZ) explants that elongate as a result of convergent extension of their neural and mesodermal tissues (Keller and Danilchik, 1988) . Keller sandwiches were formed from embryos injected with either Lrp6MO or lrp6 mRNA, and their elongation was assessed at stage 18. These explants were unable to fully elongate compared with control explants (Fig. 2C) , which indicates defective convergent extension. Again, the effect of Lrp6MO in blocking explant elongation was not rescued by co-injection of ␤-catenin mRNA (see Fig. S1 in the supplementary material). Taken together, our embryo and explant data support a role for Lrp6 in controlling convergentextension movements during early Xenopus embryogenesis.
Lrp6 affects mesodermal cell morphology, motility and actin rearrangement
Cell intercalation drives mesodermal convergent extension during vertebrate development. To intercalate, cells acquire an elongated shape and form cytoplasmic processes along their long axes. These changes in morphology are thought to be actin driven (Keller et al., 2003) .
To assess whether the overall morphology, arrangement and motility of marginal zone cells is affected by loss of Lrp6 function, we performed live cell analysis in open-faced 'shaved' Keller explants (Shih and Keller, 1992a ) from the marginal zone (Tahinci and Symes, 2003) . Stbm, a Wnt/PCP signaling component, has been shown to block convergent extension in 4099 RESEARCH ARTICLE Lrp6 regulates convergent extension show alterations in motility, shape, orientation, protrusion distribution along the cell periphery and protrusion stability as indicated in the bar charts. Outlines of randomly chosen cells were traced throughout each movie, and traces from the first (red) and last (blue) frame were superimposed to assess cell translocation. For measuring protrusion distributions, each cell was divided into four quadrants emanating from the center (black lines), and each quadrant was subdivided into two sectors by marking the midpoint along the cell membrane (green lines). Each protrusion was assigned to the sector to which it most closely localized (long axis in blue, short axis in red). The angle () between the long axis of the cell and the mediolateral axis (purple line) of the explant was used to calculate its orientation in the explant. Protrusion stability was measured by counting the number of stable (present throughout the 15 minute movie) and transient protrusions (appearing after the first frame and/or disappearing before the last). dorsal explants (Darken et al., 2002) . Shaved Keller explants of DMZ cells injected with Lrp6MO show slower motility and resemble cells overexpressing Stbm (Fig. 3A) . Cells in these explants have smaller length-to-width ratios (i.e. rounder) and reduced ability to orient along the mediolateral embryonic axis compared to control. Protrusions of these cells are predominantly oriented along their short axes and are transient compared with those of control cells, resembling cells overexpressing Stbm. Ventral marginal zone (VMZ) cells injected with stbm mRNA or Lrp6MO show increased cell motility, reflecting possible stimulation of Wnt/PCP signaling (Fig. 3A) .
To determine whether Lrp6 downregulation can also promote changes in the behavior of isolated cells, we assessed the morphology of cells dissociated from the DMZ or VMZ of Lrp6MO-injected embryos (Fig. 3B) . The majority of DMZ cells from GFP-injected control embryos become elongated with cytoplasmic protrusions along their long axes. Equivalently staged VMZ cells, by contrast, are round with most protrusions distributed along their short axes. DMZ cells from Lrp6MO-injected embryos are rounder than controls and have a large number of protrusions around their periphery; a similar phenotype is observed for DMZ cells injected with Wnt11 or Stbm, regulators of Wnt/PCP signaling. VMZ cells injected with Wnt11 or Stbm are rounder than control cells and have a greater number of small processes along their long axes; VMZ cells injected with Lrp6MO are slightly more elongated than control cells and similarly have a large number of protrusions along their long axes. Together, the effects of loss of Lrp6 function on the morphology of cells from marginal zone tissues resemble those of Wnt11 and Stbm. We propose that these differences in the morphologies of cells isolated from control versus Lrp6 morphant embryos may also affect the behavior of these cells in the context of an embryo or explant.
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Lrp6 is localized in a polarized fashion in dorsal marginal zone cells
In the Drosophila wing, proteins that confer planar cell polarity through Wnt/PCP signaling are asymmetrically distributed in epithelial cells: inhibitors localize proximally and activators distally (Klein and Mlodzik, 2005) . In vertebrates, asymmetric distribution of several Wnt/PCP components has also been reported: Dvl2 (Wang et al., 2005) , prickle (Ciruna et al., 2006) and PKC (Kinoshita et al., 2003) . We tested whether Lrp6 has a polarized distribution in intercalating mesodermal cells. Animal caps injected with VSVGlrp6 mRNA show a uniform subcellular staining pattern (Fig. 4A) . Strikingly, treatment of animal caps with activin at concentrations that induce dorsal mesoderm and promote elongation (via a mechanism that is believed to recapitulate convergent extension) causes, indirectly, asymmetric relocalization of Lrp6 (Fig. 4A) . Confirming these findings, cryosections of whole embryos injected with VSVG-lrp6 show that Lrp6 has a uniform distribution in cells of the animal pole and VMZ in early gastrulae, but not the DMZ (see Fig. S2 in the supplementary material). This spatial distribution of Lrp6 is reminiscent of the localization of inhibitory PCP proteins in the Drosophila wing and eye (Klein and Mlodzik, 2005) .
We also observe a polarized subcellular distribution for Lrp6 in whole DMZ explants. Embryos were injected with VSVG-tagged lrp6 mRNA (at a concentration that did not perturb embryonic morphology), and open-faced shaved Keller explants of the DMZ were stained with anti-VSVG antibody. To more faithfully assess Lrp6 localization, explants were not cultured prior to fixation and staining for Lrp6. VSVG-Lrp6 predominantly localized to the posterior surface of intercalating DMZ cells throughout the whole explant (Fig. 4B ). This distribution of VSVG-Lrp6 in DMZ cells is unlikely to be due to oriented anteroposterior cell overlapping (Winklbauer and Nagel, 1991) because cortical actin staining can clearly be seen at anterior and posterior surfaces of these cells. Reorganization of the actin cytoskeleton is a major consequence of Wnt/PCP signaling. The mechanism by which Wnt/PCP signaling impinges on the cytoskeleton, however, is still poorly understood, and a direct link between Wnt/PCP components and the actin cytoskeleton has not been established. Thus, we sought to establish an association between the actin cytoskeleton and Lrp6, a potential regulator of Wnt/PCP signaling. We injected cells of the DMZ with VSVG-lrp6 mRNA, dissociated cells at stage 10.5, and stained them with anti-VSVG antibody and Rhodamine-phalloidin (Fig. 4C) . Lrp6 was seen at the periphery of cells and was enriched adjacent to actin-rich cortical areas of cellular protrusions. This observation suggests a potential role for Lrp6 in regulating the actin cytoskeleton and is consistent with our proposed role for Lrp6 in polarized cell movement and regulation of convergent extension.
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Lrp6 negatively regulates Wnt/PCP signaling
Injection of either positive or negative regulators of Wnt/PCP signaling into animal caps inhibits explant elongation, thereby demonstrating the importance of spatial and temporal organization for proper signaling (Penzo-Mendez et al., 2003; Takeuchi et al., 2003) . To determine whether Lrp6 is a positive or negative Wnt/PCP regulator, we tested the ability of Lrp6 to oppose or reinforce the effect of sub-optimal amounts of coinjected Wnt11 by tipping the balance towards increased Wnt11 signaling (i.e. Lrp6 strengthens the Wnt11 effect) or decreased Wnt11 signaling (i.e. Lrp6 weakens the Wnt11 effect; Fig. 5A ). Injection of sub-optimal amounts of Lrp6 opposes Wnt11-induced inhibition of animal cap elongation, indicating that Lrp6 is a negative regulator of Wnt/PCP signaling. Similarly, suboptimal amounts of Wnt11 are reinforced by Lrp6MO in
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To further address the role of Lrp6 as a negative regulator of Wnt/PCP signaling, we assayed downstream molecular events. In unstimulated cells and cells with active Wnt/␤-catenin signaling, injected Dsh-GFP is predominantly cytoplasmic with a punctate pattern (Yanagawa et al., 1995) . Upon activation of Wnt/PCP signaling, Dsh-GFP localizes predominantly to the cell cortex (Yanagawa et al., 1995) . Cortical localization of Dsh-GFP is readily observed in animal caps expressing Wnt11 (Fig. 5B) . Consistent with activation of the Wnt/PCP pathway, Lrp6MO injection also results in Dsh-GFP localization to the cortex. As a control, injection of animal caps with Wnt8, which signals through the Wnt/␤-catenin pathway, does not cause cortical redistribution of Dsh-GFP.
JNK is phosphorylated as a result of Wnt/PCP signaling (Yamanaka et al., 2002) . Animal caps expressing Dsh or Lrp6MO show enhanced nuclear phospho-JNK staining consistent with their roles as Wnt/PCP activators (Fig. 5C) . By contrast, ␤-catenin injections do not affect phospho-JNK. These results provide molecular evidence that Lrp6 antagonizes Wnt/PCP signaling.
A 36-residue intracellular domain of Lrp6 is sufficient to mediate its effects on convergent extension
To determine the region of Lrp6 responsible for mediating its Wnt/PCP activity, we performed structure-function analysis of its intracellular domain. Previous studies have shown that the intracellular domain of Lrp6 contains five PPP(S/T)P motifs, each of which can activate Wnt/␤-catenin signaling (Tamai et al., 2004) . C-terminal deletion mutants of Lrp6 lacking these motifs were tested for their ability to perturb convergent extension in embryos (Fig. 6A) .
Embryos injected with various Lrp6 constructs were scored as normal, or affected (mildly or severely) based on AP axes lengths as previously described (Goto and Keller, 2002) . Surprisingly, progressive C-terminal deletions of Lrp6 result in an increasing percentage of elongation defects until a 36-residue fragment (Lrp6-B) is eliminated (Fig. 6A,B) . Similar to injections of Lrp6, injections of Lrp6-B result in severe mesodermal and neural convergent-extension defects in embryos, animal caps and Keller sandwiches (Fig. 6C) . In addition, Lrp6-B potentiates the effect of Lrp6 in blocking animal cap elongation, indicating that Lrp6-B regulates convergent-extension activity in the same direction as the full-length intracellular domain (Fig. 6C) . Finally, Lrp6-B reverses the Lrp6MO-mediated block in elongation of animal caps (see Fig. S3A in the supplementary material) and Keller sandwich explants (see Fig. S3B in the supplementary material), indicating that it is sufficient to transduce a signal to the PCP branch of the Wnt pathway. RT-PCR analysis of animal caps and TOPFLASH reporter assays in HEK-293 cells reveal that Lrp6-B is unable to activate ␤-catenin-dependent transcription (Fig. 6D,E) or to act in a dominant-negative manner to inhibit Wnt-mediated induction of ␤-catenin targets (Fig. 6D,E) . Thus, Lrp6 appears to mediate its convergent-extension activity through Lrp6-B, independent of its role in regulating ␤-catenin-mediated transcription (Yokota et al., 2003) . This result is consistent with our observation that co-injection of ␤-catenin rescues the defects in Wnt/␤-catenin, but not Wnt/PCP signaling caused by injection of Lrp6MOs into Xenopus embryos and explants ( Fig. 1B and see Fig. S1A ,B in the supplementary material).
Phalloidin staining of DMZ and VMZ cells expressing Lrp6-B reveals that this domain of Lrp6 alters the bipolar morphology of cells in the DMZ (see Fig. S2C in the supplementary material) without activating cell motility in the VMZ (see Fig. S2D 
Coupling of the Wnt/␤-catenin and Wnt/PCP pathways at the level of Lrp6
Identification of Lrp6-B as a region of Lrp6 that can inhibit Wnt/PCP signaling without activating Wnt/␤-catenin targets indicates that these two activities of Lrp6 require distinct domains. It is not clear, however, whether they are physiologically coupled. To address this question, we used a non-phosphorylatable mutant of the intracellular domain of Lrp6, Lrp6-m5, in which all serine/threonine residues within the PPP(S/T)P motifs are replaced by alanines. This mutant, which contains the Lrp6-B sequence, acts in a dominant-negative manner to inhibit Wnt/␤-catenin signaling (Tamai et al., 2004) . Interestingly, injection of Lrp6-m5 at concentrations that block Wnt/␤-catenin signaling by RT-PCR (data not shown) failed to inhibit animal cap elongation (Fig. 7A) , suggesting that Lrp6 phosphorylation is 4103 RESEARCH ARTICLE Lrp6 regulates convergent extension necessary for Lrp6 to mediate its Wnt/PCP activity (possibly by relieving steric inhibition to expose the Lrp6-B region). This result is consistent with our observation of increased Wnt/PCP activity upon progressive C-terminal truncations of Lrp6 regions necessary for Wnt/␤-catenin signaling (Fig. 6A) .
Activation of Wnt/PCP signaling has been suggested to antagonize Wnt/␤-catenin signaling (Peters et al., 1999; Yan et al., 2001; Kuhl et al., 2001; Schwarz-Romond et al., 2002) . To test whether inhibition of this antagonistic activity is sufficient to promote Wnt/␤-catenin signaling, we co-injected Lrp6-B mRNA with sub-optimal amounts of the Wnt/␤-catenin ligand, Wnt8, and scored embryos for axis duplication, an in vivo read-out for Wnt/␤-catenin activation. Lrp6-B injection potentiates the effects of Wnt8 in inducing axis duplication (Fig. 7B) , indicating that inhibition of Wnt/PCP signaling at the level of Lrp6 potentiates Wnt/␤-catenin signaling. Based on these findings, we propose a model in which Lrp6, through its interactions with cytoplasmic factors via an intracellular 36-residue domain, acts as a switch between Wnt/␤-catenin and Wnt/PCP signaling (Fig. 7C) .
DISCUSSION
In our current study, we show that Lrp6 regulates convergentextension movements by downregulating Wnt/PCP signaling. Using gain-and loss-of-function studies in Xenopus embryos and explants, we show that Lrp6 regulates convergent-extension movements without affecting mesodermal tissue patterning. Lrp6 controls the shape, polarity and motility of mesodermal cells and is asymmetrically localized to the posterior surface of cells that undergo convergent extension. We show that Lrp6 antagonizes the activity of Wnt11, an activator of Wnt/PCP signaling, in an animal cap elongation assay and that Lrp6MO potentiates the activity of Wnt11 in this assay. Furthermore, we detect enhanced cortical localization of Dsh and phosphorylation of JNK in Lrp6 morphant tissues, both of which are consistent with a role for Lrp6 as an inhibitor of Wnt/PCP signaling. We have identified a 36-residue domain of Lrp6 with Wnt/PCP activity that is distinct from the previously characterized PPP(S/T)P motifs of Lrp6 that are necessary for Wnt/␤-catenin signaling. Based on these findings, we propose a model in which Lrp6 regulates convergent extension by coordinating a molecular switch from Wnt/PCP to Wnt/␤-catenin signaling.
The role of Lrp6 in mediating the switch from Wnt/PCP to Wnt/␤-catenin signaling From this study we provide evidence for interaction between the Wnt/␤-catenin and Wnt/PCP pathways at the level of Lrp6. We show that injection of mRNA encoding a small intracellular domain of Lrp6, Lrp6-B, inhibits Wnt/PCP signaling while potentiating Wnt/␤-catenin signaling. Our data also indicate that Lrp6 activation (via activation of Wnt/␤-catenin signaling) is a prerequisite for its ability to inhibit Wnt/PCP signaling (Fig. 7C) . Our data suggest that coupling of Wnt/PCP inhibition with activation of Wnt/␤-catenin is embedded at the structural level of Lrp6.
Because Lrp6 activation is necessary for inhibition of Wnt/PCP, it stands to reason that canonical Wnt inhibitors that bind Lrp6 (e.g. Dkks, SOST) would potentiate the Wnt/PCP pathway by relieving inhibition by Lrp6. Wnt-Fz-Lrp6 interactions can in turn be influenced by tissue-specific factors, depending on the context (Tao et al., 2005) . This model is reminiscent of the Hedgehog signaling pathway where signaling occurs through another seven-pass transmembrane protein, Smoothened, upon relief of inhibition by the Hedgehog receptor, Patched (Cohen, 2003) .
Inhibition of Wnt/PCP by Lrp6 occurs through intracellular interactions
Recently, Dkk1 has been proposed to activate Wnt/PCP signaling by interacting with glypican 4 (Caneparo et al., 2007) . Our observation that Lrp6 inhibits Wnt/PCP signaling is unlikely to be a consequence of disruption of the Dkk1-glypican 4-mediated activation of Wnt/PCP signaling because our gain-of-function studies were conducted with the intracellular domain of Lrp6, which presumably cannot bind to Dkk1, a secreted protein. Based on our results, it is possible that some of the effect of Dkk1 on Wnt/PCP signaling may be indirectly due to its interaction with Lrp6. Interestingly, Wise, a context-dependent activator or inhibitor of Wnt signaling, can both bind Lrp6 and affect Wnt/PCP signaling, as evidenced by its ability to block elongation in activin-treated animal caps (Itasaki et al., 2003) .
One obvious mechanism by which Lrp6 could inhibit Wnt/PCP signaling would be through its interaction with the scaffold protein Axin. Axin can bind directly to Dsh (Li et al., 1999) , and it is possible that, indirectly, Lrp6 could decrease the activity of Dsh in the Wnt/PCP pathway and concomitantly increase its activity in the Wnt/␤-catenin pathway. We believe that this scenario is unlikely because the Lrp6 regions that have been shown to bind Axin and mediate Wnt/␤-catenin signaling, the PPP(S/T)P motifs, are distinct from the Lrp6 domain that we show inhibits Wnt/PCP signaling. It is possible that Lrp6 directly interacts with Dsh to inhibit Wnt/PCP signaling. To our knowledge, however, there has been no reported interaction between Lrp6 and Dsh, and we have been unsuccessful in demonstrating interaction between either the full intracellular domain of Lrp6 or Lrp6-B and Dsh (data not shown). Thus, we favor a model in which Lrp6 mediates its Wnt/PCP activity through its interaction with Wnt/PCP pathway components that function downstream of Dsh.
Lrp6 localizes to the posterior edge of intercalating axial mesodermal cells
Core Fz/PCP components have been shown to have asymmetrical subcellular localization patterns in Drosophila wing cells. Positive regulators of Fz/PCP signaling are localized distally at the site of actin-rich hair formation, whereas negative regulators are localized proximally (reviewed by Jenny and Mlodzik, 2006) . Similar observations have been made in cochlea sensory hair cells of vertebrates. For example, Dvl2 is localized to the site of actin-rich stereocilia formation (Wang et al., 2005) in the outer cell cortex, whereas Vangl2 [the mouse ortholog of Stbm; Montcouquiol et al. (Montcouquiol et al., 2006) ] is localized to the opposing inner side.
Demonstration of asymmetric subcellular localization of Wnt/PCP components during vertebrate convergent extension has been less straightforward. Initial studies in cultured Xenopus explants indicated that Dsh and PKC are enriched along the mediolateral axis of cells undergoing convergent extension (Kinoshita et al., 2003) . Prickle, a Wnt/PCP regulator that interacts with Dsh, has recently been shown to localize to the anterior end of notochord and neurectoderm cells during zebrafish neurulation (Ciruna et al., 2006) . We have, however, been unable to observe polarized localization of either Dsh-GFP or GFP-Prickle in the DMZ. Furthermore, their localization is not altered by injection of lrp6 mRNA or Lrp6MO (data not shown).
Our results show that Lrp6, a core component of the Wnt/␤-catenin pathway, is localized to the posterior end of intercalating mesodermal cells of the early Xenopus gastrula. It is tempting to speculate that Lrp6 may indirectly inhibit Dsh activity in the posterior end of these cells during gastrulation. Interestingly, these mesodermal cells intercalate in a mediolateral fashion, perpendicular to the axis of Lrp6 polarization. This suggests that other signaling pathways (in addition to Wnt/PCP) may also act to control cell polarity during convergent extension (Hyodo-Miura et al., 2006) . Further characterization of the Wnt/PCP signaling cascade downstream of Lrp6 will probably provide clues as to the spatial and temporal activation of Wnt/PCP components during vertebrate convergent extension.
